>99% Purity
HPLC Verified
QC Tested
Every Batch
Fast Ship
24-48 Hours
Retatrutide
Purity: >99%
Select vial size:
Retatrutide (LY3437943) is a novel triple agonist peptide targeting GIP, GLP-1, and glucagon receptors. It represents a new frontier in metabolic research as the first triple incretin receptor agonist to enter advanced clinical trials. For laboratory research use only.
In Stock — Ships within 24-48 hours
USPS Priority ($15) or Express ($25) shipping
For laboratory and research use only
- Name: Retatrutide
- Dosage / Size: 20mg
- Purity: >99% (HPLC Verified)
- Category: GLP-1 Agonists
- Form: Lyophilized powder
- Intended Use: Laboratory & scientific research only
Research Studies & Clinical Trials
Phase 1 Studies
NCT04143802 First-in-human, randomized, placebo-controlled study evaluating single and multiple ascending doses of retatrutide. Published in The Lancet (2022). Demonstrated favorable pharmacokinetic profile and dose-dependent metabolic effects.
Phase 2 Studies
NCT04881706 (Obesity Study) A 48-week, Phase 2, randomized, double-blind, placebo-controlled study. Published in NEJM (2023) by Jastreboff et al. Key findings:
- Dose-dependent effects observed across 1mg, 4mg, 8mg, and 12mg doses
- 12mg dose group showed mean body weight reduction of 24.2% at 48 weeks
- Most common adverse events were gastrointestinal in nature
NCT04867785 (Type 2 Diabetes Study) A 36-week Phase 2 study evaluating retatrutide in research subjects with type 2 diabetes. Published in The Lancet (2023). Demonstrated significant A1C reductions across all dose levels.
Phase 3 Program (TRIUMPH)
TRIUMPH-1 Ongoing Phase 3 study evaluating retatrutide in subjects without diabetes.
TRIUMPH-2 Ongoing Phase 3 study in subjects with type 2 diabetes.
TRIUMPH-3 MASH/NASH-focused Phase 3 trial.
Triple Agonism Research
Preclinical research published in Cell Metabolism (2022) demonstrates the synergistic effects of simultaneous GIP, GLP-1, and glucagon receptor activation on energy expenditure and metabolic parameters.
Customer Reviews
First-class triple agonist. Our GIP/GLP-1/glucagon receptor research has never had better results.
Hard to find retatrutide at this purity level. Bausch delivered exactly what was described.
Batch-to-batch consistency is excellent. Our metabolic models are producing clean data.
Very good quality. CoA looks solid. Shipping was a little slow but well-packaged.
Best source for retatrutide. Our lab confirmed >99% purity on independent testing.
Impressive product. The triple agonism profile in our in vitro models was exactly what we expected.
Solid reputation, solid product. Fast shipping and excellent purity.
Our metabolic research team is thrilled. Clean HPLC, accurate mass, exactly as expected.
Good product. Good price point for a triple agonist. Will definitely reorder.
Customers Also Viewed
View all
Research Use Only
All products sold by Bausch Pharma are intended strictly for laboratory and scientific research purposes. These products are not intended for any other use. By browsing and purchasing from this website, you confirm you are at least 21 years of age and a qualified researcher.